Medical management of malignant bowel obstruction: our center experience

Authors:

Abstract
Background: Malignant bowel obstruction (MBO) is common in advanced cancer patients. It developes more likely in gastrointestinal or gynaecological tumors with abdominal burden, but it can arise in other cancers too. Its typical symptomps, nausea, vomiting, abdominal pain, impact negatively on patients’ daily life, making MBO a very disabling condition. Surgery is a treatment option only for selected patients who meet surgical criteria. Other patients are usually treated with nasogastric tube to decompress bowel distension, fasting and supportive care. Studies showed that medical treatment with metoclopramide, octreotide and dexamethasone can significatively improve symptoms and quality of life. Octreotide has both antisecretive effects which reduce intestinal fluids improving nausea and vomiting and the power of reducing bowel motility, that can weaken abdominal cramps. Here, we report our center experience of MBO medical treatment.